HealthDay - WEDNESDAY, April 30 (HealthDay News) — Patients with mild
Alzheimer’s disease who took 800 milligrams of the drug tarenflurbil twice
a day had less decline in functional ability than those who took a
placebo, according to a British phase II trial.
No user commented in " Experimental Drug Eases Symptoms of Mild Alzheimer’s (HealthDay) "
Follow-up comment rss or Leave a Trackback